Incyte (INCY) Operating Income (2010 - 2026)
Incyte (INCY) reported Operating Income of $697.9 million for Q2 2026, up 31.6% from $530.31 million a year earlier and up 131.8% from the prior quarter.
Powered by 
Analysis
Incyte (INCY) Operating Income (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Incyte's Operating Income came in at $1.78 billion, up 50.3% year-over-year; for FY2025, it came in at $1.51 billion.
- By year, Operating Income came in at $61.37 million in FY2024 (-90.1%), $620.53 million in FY2023 (+7.1%), $579.44 million in FY2022 (-1.1%) and $585.78 million in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Operating Income in data going back to Q1 2010.
- Year over year, Operating Income has now increased in each of the last four quarters, with growth averaging 63.7% over the last seven quarters.
- The high point for year-over-year Operating Income in five years was Q1 2024 (growth of 271.0%); the low point was Q1 2023 (a decline of 78.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $301.12 million (Q1 2026), $335.86 million (Q4 2025) and $443.52 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Incyte | 24.39 Bn | 9.33 Bn | 1.57 Bn | 697.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 697.90 Mn |
| Mar 31, 2026 | 301.12 Mn |
| Dec 31, 2025 | 335.86 Mn |
| Sep 30, 2025 | 443.52 Mn |
| Jun 30, 2025 | 530.31 Mn |
| Mar 31, 2025 | 205.17 Mn |
| Dec 31, 2024 | 301.51 Mn |
| Sep 30, 2024 | 146.09 Mn |
| Jun 30, 2024 | -478.13 Mn |
| Mar 31, 2024 | 91.90 Mn |
| Dec 31, 2023 | 187.27 Mn |
| Sep 30, 2023 | 214.71 Mn |
| Jun 30, 2023 | 193.78 Mn |
| Mar 31, 2023 | 24.77 Mn |
| Dec 31, 2022 | 70.09 Mn |
| Sep 30, 2022 | 138.38 Mn |
| Jun 30, 2022 | 254.43 Mn |
| Mar 31, 2022 | 116.54 Mn |
| Dec 31, 2021 | 110.73 Mn |
| Sep 30, 2021 | 235.41 Mn |
API Access
Incyte Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=INCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();